Hi, I recently have heard about Pfizer spinning off their off-patent branded drugs and merge it with Mylan to create a new entity Viatris. How will Trading 212 handle this? As if I am not wrong, shareholders will receive shares of Viatris. Are we receiving the shares also?
I’d like to know this too as I’ve only just found out about the spin off.